ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma | Children’s Hospital of Philadelphia / John Maris, MD | Reach Grants | 2016 | Pennsylvania |
Targeting RNA Helicase DDX3 to Treat Recurrent High Grade Sarcoma | The Johns Hopkins University School of Medicine / David Loeb, MD, PhD | Reach Grants | 2013 | Maryland |
Identifying a Therapeutic Partner for TAK228 for Pediatric Phase II Brain Tumor Studies | The Johns Hopkins University School of Medicine / Eric H. Raabe, MD/PhD | Reach Grants | 2018 | Maryland |
Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma | The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D. | Reach Grants | 2014 | California |
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL | University of Colorado Denver / Doug Graham, MD, PhD | Reach Grants | 2013 | Colorado |
Immunoglobulin High-Throughput Sequencing for Refining Risk Stratification in Infant B-ALL | University of Rochester / Carol Fries Simpson, MD | Reach Grants | 2023 | New York |
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma | Van Andel Research Institute / Patrick Grohar, MD, PhD | Reach Grants | 2013 | Michigan |
A Novel Target for Neuroblastoma Treatment | Beckman Research Institute of City of Hope / Linda Malkas, Ph.D. | Reach Grants | 2014 | California |
Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma | Beckman Research Institute of City of Hope / Margarita Gutova, MD | Reach Grants | 2013 | California |
Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma | Duke University Medical Center / Gerard Blobe, MD, PhD | Reach Grants | 2013 | North Carolina |